These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 28915852)

  • 21. Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia.
    Wilke C; Gillardon F; Deuschle C; Hobert MA; Jansen IE; Metzger FG; Heutink P; Gasser T; Maetzler W; Blauwendraat C; Synofzik M
    Neurodegener Dis; 2017; 17(2-3):83-88. PubMed ID: 27760429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
    Woollacott IOC; Nicholas JM; Heller C; Foiani MS; Moore KM; Russell LL; Paterson RW; Keshavan A; Schott JM; Warren JD; Heslegrave A; Zetterberg H; Rohrer JD
    Dement Geriatr Cogn Disord; 2020; 49(1):56-76. PubMed ID: 32344399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GRN mutation in a patient with a behavioral variant of frontotemporal lobar degeneration (bvFTD).
    Walczysková S; Ressner P; Hilscherová Š; Kotlas J; Konrád J; Svobodová V
    Folia Neuropathol; 2017; 55(1):67-72. PubMed ID: 28430294
    [No Abstract]   [Full Text] [Related]  

  • 24. A novel GRN mutation (GRN c.708+6_+9delTGAG) in frontotemporal lobar degeneration with TDP-43-positive inclusions: clinicopathologic report of 6 cases.
    Bit-Ivan EN; Suh E; Shim HS; Weintraub S; Hyman BT; Arnold SE; McCarty-Wood E; Van Deerlin VM; Schneider JA; Trojanowski JQ; Frosch MP; Baker MC; Rademakers R; Mesulam M; Bigio EH
    J Neuropathol Exp Neurol; 2014 May; 73(5):467-73. PubMed ID: 24709683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symmetrical corticobasal syndrome caused by a novel C.314dup progranulin mutation.
    Dopper EG; Seelaar H; Chiu WZ; de Koning I; van Minkelen R; Baker MC; Rozemuller AJ; Rademakers R; van Swieten JC
    J Mol Neurosci; 2011 Nov; 45(3):354-8. PubMed ID: 21863316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrafamilial clinical phenotypic heterogeneity with progranulin gene p.Glu498fs mutation.
    Larner AJ
    J Neurol Sci; 2012 May; 316(1-2):189-90. PubMed ID: 22280948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The unexpected co-occurrence of GRN and MAPT p.A152T in Basque families: Clinical and pathological characteristics.
    Moreno F; Indakoetxea B; Barandiaran M; Caballero MC; Gorostidi A; Calafell F; Gabilondo A; Tainta M; Zulaica M; Martí Massó JF; López de Munain A; Sánchez-Juan P; Lee SE
    PLoS One; 2017; 12(6):e0178093. PubMed ID: 28594853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cluster of progranulin C157KfsX97 mutations in Southern Italy: clinical characterization and genetic correlations.
    Coppola C; Saracino D; Puoti G; Lus G; Dato C; Le Ber I; Pariente J; Caroppo P; Piccoli E; Tagliavini F; Di Iorio G; Rossi G
    Neurobiol Aging; 2017 Jan; 49():219.e5-219.e13. PubMed ID: 27814992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One novel GRN null mutation, two different aphasia phenotypes.
    Coppola C; Oliva M; Saracino D; Pappatà S; Zampella E; Cimini S; Ricci M; Giaccone G; Di Iorio G; Rossi G
    Neurobiol Aging; 2020 Mar; 87():141.e9-141.e14. PubMed ID: 31837909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The novel GRN g.1159_1160delTG mutation is associated with behavioral variant frontotemporal dementia.
    Calvi A; Cioffi SM; Caffarra P; Fenoglio C; Serpente M; Pietroboni AM; Arighi A; Ghezzi L; Gardini S; Scarpini E; Galimberti D
    J Alzheimers Dis; 2015; 44(1):277-82. PubMed ID: 25261445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrafamilial phenotypic heterogeneity in a Taiwanese family with a MAPT p.R5H mutation: a case report and literature review.
    Lin HC; Lin CH; Chen PL; Cheng SJ; Chen PH
    BMC Neurol; 2017 Sep; 17(1):186. PubMed ID: 28923025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic variability of familial and sporadic Progranulin p.Gln257Profs*27 mutation.
    Pires C; Coelho M; Valadas A; Barroso C; Pimentel J; Martins M; Duyckaerts C; de Mendonça A; Verdelho A; Miltenberger-Miltenyi G
    J Alzheimers Dis; 2013; 37(2):335-42. PubMed ID: 23813535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rare exonic variant affects GRN splicing and contributes to frontotemporal lobar degeneration.
    Wauters E; Gossye H; Frydas A; Sieben A; Van Broeckhoven C
    Neurobiol Aging; 2023 Oct; 130():61-69. PubMed ID: 37459659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration.
    Yu CE; Bird TD; Bekris LM; Montine TJ; Leverenz JB; Steinbart E; Galloway NM; Feldman H; Woltjer R; Miller CA; Wood EM; Grossman M; McCluskey L; Clark CM; Neumann M; Danek A; Galasko DR; Arnold SE; Chen-Plotkin A; Karydas A; Miller BL; Trojanowski JQ; Lee VM; Schellenberg GD; Van Deerlin VM
    Arch Neurol; 2010 Feb; 67(2):161-70. PubMed ID: 20142524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation.
    Bonvicini C; Milanesi E; Pilotto A; Cattane N; Premi E; Archetti S; Padovani A; Gennarelli M; Borroni B
    Neurobiol Aging; 2014 May; 35(5):1206-11. PubMed ID: 24368088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma progranulin levels in cortical dementia phenotypes with asymmetric perisylvian atrophy.
    Gómez-Tortosa E; Guerrero-López R; Gil-Neciga E; Franco E; del Ser T; Jiménez Escrig A; Pérez-Pérez J; Sainz MJ
    Eur J Neurol; 2013 Sep; 20(9):1319-24. PubMed ID: 23724906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort.
    Van Langenhove T; van der Zee J; Gijselinck I; Engelborghs S; Vandenberghe R; Vandenbulcke M; De Bleecker J; Sieben A; Versijpt J; Ivanoiu A; Deryck O; Willems C; Dillen L; Philtjens S; Maes G; Bäumer V; Van Den Broeck M; Mattheijssens M; Peeters K; Martin JJ; Michotte A; Santens P; De Jonghe P; Cras P; De Deyn PP; Cruts M; Van Broeckhoven C
    JAMA Neurol; 2013 Mar; 70(3):365-73. PubMed ID: 23338682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images.
    Whitwell JL; Boeve BF; Weigand SD; Senjem ML; Gunter JL; Baker MC; DeJesus-Hernandez M; Knopman DS; Wszolek ZK; Petersen RC; Rademakers R; Jack CR; Josephs KA
    Eur J Neurol; 2015 May; 22(5):745-52. PubMed ID: 25683866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel missense progranulin gene mutation associated with the semantic variant of primary progressive aphasia.
    Cerami C; Marcone A; Galimberti D; Villa C; Fenoglio C; Scarpini E; Cappa SF
    J Alzheimers Dis; 2013; 36(3):415-20. PubMed ID: 23624518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid biomarkers in Progranulin mutations carriers.
    Carecchio M; Fenoglio C; Cortini F; Comi C; Benussi L; Ghidoni R; Borroni B; De Riz M; Serpente M; Cantoni C; Franceschi M; Albertini V; Monaco F; Rainero I; Binetti G; Padovani A; Bresolin N; Scarpini E; Galimberti D
    J Alzheimers Dis; 2011; 27(4):781-90. PubMed ID: 21891865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.